Transcriptional coactivators of β-catenin, BCL9 and BCL9l, redundantly demonstrated CRC-specific upregulation, and their loss suppressed intestinal tumorigenesis in a mouse model [173]. Here, BCL9L is linked to colorectal carcinoma.